Talis Biomedical Corporation

TLIS · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$59,867$70,337$76,732$87,996
Short-Term Investments$0$0$0$0
Receivables$0$6$50$5
Inventory$0$0$0$0
Other Curr. Assets$3,734$827$901$1,531
Total Curr. Assets$63,601$71,170$77,683$89,532
Property Plant & Equip (Net)$8,332$9,782$15,449$16,154
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$766$1,542$1,542$1,542
Tax Assets$0$0$3,666$0
Other NC Assets$0$0$1,542$0
Total NC Assets$9,098$11,324$20,657$17,696
Other Assets$0$0$0$0
Total Assets$72,699$82,494$98,340$107,228
Liabilities
Payables$3,790$3,619$1,339$2,697
Short-Term Debt$2,923$2,902$2,882$0
Tax Payable$0$0$0$0
Deferred Revenue-$3,557$0$0$0
Other Curr. Liab.$1,268-$944$954$2,255
Total Curr. Liab.$8,196$9,471$8,772$8,450
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$15,877$16,339$16,786$17,222
Other Liabilities$0$0$0$0
Cap. Leases$18,800$16,339$16,786$20,083
Total Liabilities$24,073$25,810$29,224$25,672
Equity
Pref Stock$3$3$3$3
Common Stock$0$0$0$0
Retained Earnings-$561,845-$552,996-$539,961-$526,501
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity$48,626$56,684$69,116$81,556
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$72,699$82,494$98,340$107,228
Net Debt-$56,944-$67,435-$73,850-$87,996